APOE and Alzheimer disease: Additionally, compared to AD patients with the APOE ε3/ε3 genotype, those with the ε4/ε4 genotype exhibit decreased expression of several antiviral defence genes, such as IFITM2, IFITM3, IFNAR1 and LY6E [127] (Fig. 3d).